Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Comment by wizzdumbon Oct 17, 2022 3:50pm
121 Views
Post# 35029820

RE:Microbix T.MBX could test 52 week highs....

RE:Microbix T.MBX could test 52 week highs....Possible releases that could come at any time:

Fourth building - this will confirm they are basically sold out of semi automated QAPs

Additional QAPs formal announcements with diagnostic test manufacturers - one so far "many" more to come

New VTM orders - only large or strategically significant one would likely be announced ( large Ontario fall order or something with new province)

MonkeyPox QAP - likely not huge from revenue perspective but could drive more exposure/coverage which we badly need

Kinlytic - still active discussions happening and hey I'm allowed to dream 

They have recently followed through with the first QAPs announcement and the share buyback and Cameron has good track record for delivering on commitments so  IMHO all of these are possible and highly likely, it's just the timing that is unclear. 
<< Previous
Bullboard Posts
Next >>